Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sperker

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolismB Sperker, T E Mürdter, M Schick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 24, 1999
Quantitative immunohistochemical analysis of the glutathione S-transferase GSTM1: in situ phenotyping in archival materialP Fritz, B Sperker, T E Mürdter, et al.
Pneumologie (Stuttgart, Germany)|January 2, 2001
[Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]T E Mürdter, A Linder, G Friedel, et al.
Cancer Research|March 27, 1998
Elucidation of the mechanism enabling tumor selective prodrug monotherapyK Bosslet, R Straub, M Blumrich, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 29, 2000
Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targetingB Sperker, U Werner, T E Mürdter, et al.
Cancer Research|June 15, 1997
Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor siteT E Mürdter, B Sperker, K T Kivistö, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolismB Sperker, T E Mürdter, M Schick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 24, 1999
Quantitative immunohistochemical analysis of the glutathione S-transferase GSTM1: in situ phenotyping in archival materialP Fritz, B Sperker, T E Mürdter, et al.
Pneumologie (Stuttgart, Germany)|January 2, 2001
[Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]T E Mürdter, A Linder, G Friedel, et al.
Cancer Research|March 27, 1998
Elucidation of the mechanism enabling tumor selective prodrug monotherapyK Bosslet, R Straub, M Blumrich, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 29, 2000
Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targetingB Sperker, U Werner, T E Mürdter, et al.
Cancer Research|June 15, 1997
Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor siteT E Mürdter, B Sperker, K T Kivistö, et al.
Pageof 2